No Data
No Data
Express News | Needham Reiterates Buy on Artiva Biotherapeutics, Maintains $23 Price Target
Artiva Biotherapeutics Analyst Ratings
Artiva Biotherapeutics, Inc. (ARTV) Gets a Buy From TD Cowen
Artiva Biotherapeutics 2024 EPS $(5.81), Total Revenue $251K Down From $33.49M YoY
Artiva Biotherapeutics Reports Full Year 2024 Results and Updates on AlloNK Autoimmune Program With Key Leadership Strengthening
Express News | Artiva Biotherapeutics : Initial Data for Allonk From Autoimmune Program Expected H1 2025